Novartis Motion Is Wolf In Sheep's Clothing: Plaintiffs

Law360, New York (September 4, 2007, 12:00 AM EDT) -- Plaintiffs in the consolidated litigation over bone drugs Aredia and Zometa have slammed Novartis Pharmaceutical Corp.'s bid to break up their proposed classes as a veiled move for dismissal.

The suits, now consolidated in a Nashville district court, all accuse Novartis of strict liability and negligence in the production and distribution of the two drugs, which have been linked to osteonecrosis of the jaw, a condition involving painful deterioration of the jawbone.

In Wood v. Novartis, which concerned patients who had taken Aredia, and in Becker...
To view the full article, register now.